Image Description (Budesonide Inhalation Suspension 0pt25mg 2ml Carton Label)
Budesonide Suspension
Product Images NDC 62135-822
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 62135-822). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Description (Budesonide Inhalation Suspension 0pt5mg 2ml Carton Label)
Image Description (Budesonide Inhalation Suspension Graph 1)
Image Description (Budesonide Inhalation Suspension Graph 2)
Mean Change from Baseline: Nighttime Asthma Symptoms
This text appears to show a table or chart indicating the mean change from baseline in nighttime asthma symptoms. It may be comparing different treatment options, such as a placebo and two different dosages of a medication (0.25 mg twice daily and 0.5 mg twice daily). The duration of the evaluation seems to be divided into different weeks, ranging from week 0-2 to week >10-12. The specific values for the mean change are not provided in the text.*
Image Description (Budesonide Inhalation Suspension Graph 3)
Image Description (Budesonide Inhalation Suspension Picture 1)
Image Description (Budesonide Inhalation Suspension Picture 1a)
Image Description (Budesonide Inhalation Suspension Picture 2)
Image Description (Budesonide Inhalation Suspension Picture 3)
Image Description (Budesonide Inhalation Suspension Picture 4)
Image Description (Budesonide Inhalation Suspension Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
